# OnCo record dahanca-5 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/dahanca-5/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "dahanca-5" ;
  schema:name "DAHANCA 5"@en ;
  schema:description "DAHANCA 5 is the trial that made hypoxic sensitisation real in the clinic: nimorazole with radiotherapy improved control of head and neck cancer, and Denmark has used it as standard ever since."@en ;
  schema:url <https://onco.cc/trials/dahanca-5/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/S0167-8140(97)00220-X> ;
  onco:status "positive" ;
  onco:tag "radiation-wave2" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/head-and-neck/> ;
  onco:technologies <https://onco.cc/technologies/radiosensitisers/>, <https://onco.cc/technologies/tumour-hypoxia-modification/> ;
  onco:drugs <https://onco.cc/drugs/nimorazole/> ;
  onco:companies <https://onco.cc/companies/dahanca/> ;
  onco:terms <https://onco.cc/terms/tumour-hypoxia/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-overgaard-radiother-oncol/> .